Gilead's new AIDS drug may reduce viral count
Gilead Sciences Inc. said preliminary results from late stage trials of its anti-HIV treatment tenofovir show that the drug appears to be effective in reducing the presence of the
Gilead Sciences Inc. said preliminary results from late stage trials of its anti-HIV treatment tenofovir show that the drug appears to be effective in reducing the presence of the